(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-3-methoxy-2H-1-benzopyran-5,7-diol

Meciadanol

HCID 10380295CAS 65350-86-9

Grundinformationen

Standard-SMILES
CO[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1
InChIKey
PDHSAQOQVUXZGQ-JKSUJKDBSA-N
Summenformel
C16H16O6
Durchschnittliche Molmasse
304,29 g/mol
Monoisotopische Masse
304,09468823

Überblick

meciadanol has been reported in Arabidopsis thaliana with data available.

Namen und Bezeichner

Bevorzugter Name
Meciadanol
IUPAC
(2R,3S)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2H-chromene-5,7-diol
Lokaler Name
(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-3-methoxy-2H-1-benzopyran-5,7-diol
Englischer Name
(2R-trans)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-2H-1-benzopyran-5,7-diol
Summenformel
C16H16O6
Molmasse
304.29

Namen und Synonyme

MECIADANOL65350-86-93-O-methylcatechinMeciadanolum2H64SE2UXS(2R,3S)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2H-chromene-5,7-diol(2R,3S)-3-Methoxy-3',4',5,7-flavantetrolDTXSID2010243522-Methoxy-5,7,3',4'-tetrahydroxyflavan3-Mthf3',4',5,7-Tetrahydroxy-3-methoxyflavanRefChem:156201
Weitere Namen anzeigen
Zy-150292-(3,4-dihydroxyphenyl)-3-methoxy-chromane-5,7-diol2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2H-chromene-5,7-diol(2R)-2α-(3,4-Dihydroxyphenyl)-3,4-dihydro-3β-methoxy-2H-1-benzopyran-5,7-diol(2R,3S)-2α-(3,4-Dihydroxyphenyl)-3,4-dihydro-3β-methoxy-2H-1-benzopyran-5,7-diol(2R-trans)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-2H-1-benzopyran-5,7-diol2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-, (2R,3S)-
2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-DTXCID201508564265-710-7Meciadanol [INN](2R,3S)-2-(3,4-Dihydroxyphenyl)-3-methoxychroman-5,7-diolMeciadanolum [Latin]UNII-2H64SE2UXS(2R,3S)-2-(3,4-DIHYDROXYPHENYL)-3-METHOXY-3,4-DIHYDRO-2H-1-BENZOPYRAN-5,7-DIOL

Datenbank-Bezeichner

CAS
65350-86-9
PubChem CID
10380295
DTXSID
DTXSID201024352
ChEMBL
CHEMBL2106853
UNII
2H64SE2UXS
EC Number
265-710-7
Nikkaji
J23.011A

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,9
Polarare Oberfläche (TPSA)
99,4 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
2
Schwere Atome
22

Experimentelle und physikochemische Eigenschaften

LogP1.0
Endocrine DisruptorsPotential endocrine disrupting compound

Chemie und Industrie

Pharmakologische Informationen

MeSH Pharmacological Classification · 2 Einträge

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Cellular LocationsCytoplasm

Anbieter1 Anbieter

Lanospharma Laboratories Co.,Ltd13440048448 · [email protected]

Zugehörige Reaktionen

1

Verknüpfte Notizen

Wird geladen…